PUBLISHER: 360iResearch | PRODUCT CODE: 1415298
PUBLISHER: 360iResearch | PRODUCT CODE: 1415298
[186 Pages Report] The Postbiotics Market size was estimated at USD 1.97 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.21% to reach USD 3.21 billion by 2030.
Global Postbiotics Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.97 billion |
Estimated Year [2024] | USD 2.10 billion |
Forecast Year [2030] | USD 3.21 billion |
CAGR (%) | 7.21% |
The postbiotics market comprises the commercial landscape for products derived from the inanimate matter of probiotic bacteria. It includes various substances such as metabolites, cell-wall fragments, and functional proteins released after the lysis of probiotic bacteria or produced during the fermentation process. These substances have been gaining attention for their ability to confer health benefits similar to or even beyond those offered by live probiotics without the complexity of maintaining viability during storage and use. In terms of application, postbiotics are utilized in dietary supplements, pharmaceuticals, and functional foods and beverages, primarily for their gut health benefits, immune system enhancement, and anti-inflammatory properties. The end-use industries that largely incorporate postbiotics include healthcare, food & beverage, personal care, and animal feed sectors. The growing interest in gut microbiome management and preventative healthcare measures substantially influences the postbiotics application spectrum. The scope of the postbiotics market is expanding with growing research highlighting their benefits and technological advancements in fermentation and downstream processing techniques.
Regional Insights
In the USA, demand for postbiotic is buoyed by a preference for scientifically validated health products, reflected in research investments and a rising number of patents focused on optimizing postbiotic production. Similarly, Canada's market is expanding, with consumers gravitating towards natural, clean-label ingredients, and both governmental and private sectors actively funding postbiotic research. The European Union leads in postbiotic innovation, upheld by stringent health claim regulations that promote scientifically backed product development. The burgeoning interest in the Middle East and gradual market growth throughout Africa indicate a rising acknowledgment of postbiotics' potential health benefits. Asia Pacific countries, particularly China, Japan, and India, are showing strong market growth potential, driven by health-conscious consumers, significant research investments, and a receptiveness to dietary supplements.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Postbiotics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Postbiotics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Postbiotics Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Beekeepers Naturals Inc., Bioflag Group, Cargill Incorporated, Dr. Emil Nutrition, DSM-Firmenich AG, Essential Formulas Incorporated, GeneFerm Biotechnology Co., Ltd., Gundry MD, GutArmor by Get Wellness, LLC, Healist Naturals, Inc, Ildong Pharmaceutical Co., Ltd., Kerry Group PLC, Kirin Holdings Company, Limited, Lactobio A/S, Maypro Group, MCLS Europe B.V., MRM Nutrition, Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Postbiotics Inc., Probiotics Australia Pty., Ltd., Probioway Co., Ltd., Sabinsa Corporation, Silab, Symbiotec Laboratoire, T.H.T. sa, woresan GmbH, and POSTBIOTICA S.R.L..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Postbiotics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Postbiotics Market?
3. What are the technology trends and regulatory frameworks in the Postbiotics Market?
4. What is the market share of the leading vendors in the Postbiotics Market?
5. Which modes and strategic moves are suitable for entering the Postbiotics Market?